ST-segment elevation myocardial infarction (STEMI) Clinical Trials

16 recruitingLast updated: June 18, 2026

There are 16 actively recruiting st-segment elevation myocardial infarction (stemi) clinical trials across 9 countries. Studies span Not Applicable, Phase 4, Phase 3. Top locations include Zhengzhou, Henan, China, Wuhan, Hubei, China, Cairo, Egypt. Updated daily from ClinicalTrials.gov.


ST-segment elevation myocardial infarction (STEMI) Trials at a Glance

16 actively recruiting trials for st-segment elevation myocardial infarction (stemi) are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Zhengzhou, Wuhan, and Cairo. Lead sponsors running st-segment elevation myocardial infarction (stemi) studies include BrosMed Medical Co., Ltd, CSIRO, The Australian e-Health Research Centre, and Ain Shams University.

Browse st-segment elevation myocardial infarction (stemi) trials by phase

Treatments under study

About ST-segment elevation myocardial infarction (STEMI) Clinical Trials

Looking for clinical trials for ST-segment elevation myocardial infarction (STEMI)? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ST-segment elevation myocardial infarction (STEMI) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ST-segment elevation myocardial infarction (STEMI) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

left ventricular thrombusST-segment elevation myocardial infarction (STEMI)
Jilin University320 enrolled1 locationNCT05892042
Recruiting
Phase 4

Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden

ST-segment elevation myocardial infarction (STEMI)
Henan Institute of Cardiovascular Epidemiology300 enrolled1 locationNCT06769256
Recruiting
Phase 4

Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

Acute Myocardial InfarctionST-segment elevation myocardial infarction (STEMI)No-Reflow Phenomenon+1 more
National Institute of Cardiovascular Diseases, Pakistan1,148 enrolled2 locationsNCT07536802
Recruiting

Systemic Organ Communication in STEMI

ST-segment elevation myocardial infarction (STEMI)
Heinrich-Heine University, Duesseldorf1,000 enrolled1 locationNCT03539133
Recruiting

Using Cardiac MRI to Predict Outcomes in Patients With STEMI

Artificial Intelligence (AI)Ventricular DysfunctionPrognosis+4 more
Chinese PLA General Hospital1,000 enrolled1 locationNCT07072858
Recruiting
Not Applicable

Early Beta Blocker Administration in STEMI Patients With SCAI B Status

ST-segment elevation myocardial infarction (STEMI)Cardiogenic Shock Post Myocardial Infarction
Tel-Aviv Sourasky Medical Center200 enrolled1 locationNCT06967194
Recruiting
Not Applicable

Coronary Aspiration Catheter Clinical Trial

ST-segment elevation myocardial infarction (STEMI)
BrosMed Medical Co., Ltd144 enrolled1 locationNCT06951724
Recruiting

MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions

Acute Cardiovascular DiseaseNSTEMI - Non-ST Segment Elevation MIST-segment elevation myocardial infarction (STEMI)
University Hospital, Basel, Switzerland200,000 enrolled1 locationNCT06927791
Recruiting
Phase 3

The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow

ST-segment elevation myocardial infarction (STEMI)No-Reflow Phenomenon
Ain Shams University1,000 enrolled1 locationNCT06847568
Recruiting
Not Applicable

The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction

ST-segment elevation myocardial infarction (STEMI)
RenJi Hospital201 enrolled1 locationNCT06385834
Recruiting
Not Applicable

Thrombus Aspiration in STEMI Patients With High Thrombus Burden

ST-segment elevation myocardial infarction (STEMI)
Guangdong Provincial People's Hospital3,838 enrolled50 locationsNCT04212494
Recruiting
Not Applicable

Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

Percutaneous Coronary InterventionST-segment elevation myocardial infarction (STEMI)Cardioprotection
Harbin Medical University250 enrolled9 locationsNCT04912518
Recruiting

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

ST-segment elevation myocardial infarction (STEMI)
Universitas Diponegoro80 enrolled1 locationNCT06586424
Recruiting

Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI

Diabetes MellitusInsulin ResistanceNon-Alcoholic Fatty Liver Disease+1 more
German Diabetes Center300 enrolled1 locationNCT05046483
Recruiting
Phase 4

PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

ST-segment elevation myocardial infarction (STEMI)
Kindai University2,258 enrolled1 locationNCT05709626
Recruiting

Evaluation of physical exercise adherence in a Home-Based Care Model for Outpatient Cardiac Rehabilitation based on Mobile Technologies.

Outpatient, stage 2 cardiac rehabilitation of ST-Segment Elevation Myocardial Infarction (STEMI) or non-STEMI patients
CSIRO, The Australian e-Health Research Centre240 enrolled1 locationACTRN12609000251224